Old Web
English
Sign In
Acemap
>
authorDetail
>
Li Liu
Li Liu
Agios Pharmaceuticals
Medicine
Thalassemia
Immunology
Activator (genetics)
Bone marrow
2
Papers
3
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Vorasidenib (VOR; AG-881), an inhibitor of mutant IDH1 and IDH2, in patients (pts) with recurrent/progressive glioma: Updated results from the phase I non-enhancing glioma population.
2020
Journal of Clinical Oncology
Ingo K. Mellinghoff
Katherine B. Peters
Timothy F. Cloughesy
Howard A. Burris
Elizabeth A. Maher
Filip Janku
Gregory M. Cote
Macarena I. de la Fuente
Jennifer Leigh Clarke
Kha Le
Li Liu
Man Yuen
Marissa Arnofsky
Islam Hassan
Lori Steelman
Shuchi Sumant Pandya
Patrick Y. Wen
Show All
Source
Cite
Save
Citations (2)
Mitapivat (AG-348), an Oral PK-R Activator, in Adults with Non-Transfusion Dependent Thalassemia: A Phase 2, Open-Label, Multicenter Study in Progress
2019
Blood
Kevin H.M. Kuo
D. Mark Layton
Katrin Uhlig
Megan Lynch
Li Liu
Elliott Vichinsky
Show All
Source
Cite
Save
Citations (1)
1